Malaria vaccines
AssigneesSeattle Biomedical Research Institute, The United States of America as represented by the Secretary of the Army
InventorsMichal Fried, Patrick E Duffy, Susan Francis, Jason P Wendler, Theonest K Mutabingwa, Andrew Oleinikov
Life of this patent
Estimating the term…
Abstract
The invention provides isolated placental P. falciparum polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:1-4 and 6-24, and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the placental P. falciparum polypeptides of the invention, compositions comprising one or more placental P. falciparum polypeptides of the invention, methods for inducing an immune response against the placental P. falciparum polypeptides, and methods for treating and diagnosing placental malaria.
Claims3
A method for inducing an immune response against placental Plasmodium falciparum parasites in a mammalian subject, comprising administering to a mammalian subject an amount of an immunogenic composition effective to induce an immune response against placental Plasmodium falciparum parasites in the mammalian subject, wherein the immunogenic composition comprises an isolated polypeptide with at least 95% amino acid sequence identity to the amino acid sequence of SEQ ID NO:9.
Dependencies are inferred from the claim text.